Skip to main content
. 2021 Feb 10;21:100. doi: 10.1186/s12935-021-01803-4

Fig. 1.

Fig. 1

a CD133+ CSCs were enriched from human HT-29 cell line using MACS and the purity of isolated cells assessed by FITC-conjugated anti-CD133 antibody and flow cytometry analysis. b The chemical structure of T0901317. c Measuring CSCs survival after exposure to various concentrations of T0901317 (5–200 µM) using MTT assay. d The chemical structure of SR9243. e CSCs survival rate was also measured after treatment with SR9243 (25–200 nM) using MTT assay. Data confirmed a dose-dependent activity of T0901317 and SR9243 on HT-29-isolated CSCs